ANTX AN2 Therapeutics, Inc.
Fundamentals / CIK 0001880438 / USDAN2 Therapeutics, Inc. reported $81.95M in total assets and a net loss of $34.84M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ANTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$37.44M Operating profit
-
Net Income FY 2025-$34.84M GAAP bottom line
-
Diluted EPS FY 2025-$0.76 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$64.40M Total debt: --
Annual revenue and net income
5 fiscal years (2021 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Research & Development | $24.77M | $40.49M | $54.87M | $28.51M | $16.16M |
| Total Operating Expenses | $38.11M | $56.79M | $69.64M | $42.26M | $21.57M |
| Operating Income | -$38.11M | -$56.79M | -$69.64M | -$42.26M | -$21.57M |
| Interest Income | $2.93M | $5.47M | $4.86M | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$35.17M | -$51.32M | -$64.73M | -$40.96M | -$21.54M |
| Basic EPS | -$1.16 | -$1.72 | -$2.74 | -$2.79 | -$10.64 |
| Diluted EPS | -$1.16 | -$1.72 | -$2.74 | -$2.79 | -$10.64 |
| Basic Shares Outstanding | 30.2M | 29.8M | 23.6M | 15.3M | 2.6M |
| Diluted Shares Outstanding | 30.2M | 29.8M | 23.6M | 15.3M | 2.6M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $5.72M | $6.02M | $6.74M | $6.88M | $7.00M | $3.20M | $7.69M | $5.40M |
| Total Operating Expenses | $8.67M | $8.90M | $10.55M | $9.32M | $10.04M | $7.22M | $11.54M | $8.60M |
| Operating Income | -$8.67M | -$8.90M | -$10.55M | -$9.32M | -$10.04M | -$7.22M | -$11.54M | -$8.60M |
| Interest Income | $713K | $720K | $523K | $605K | $687K | $754K | $888K | $1.08M |
| Net Income | -$7.96M | -$8.19M | -$10.03M | -$8.67M | -$9.35M | -$6.46M | -$10.65M | -$7.52M |
| Basic EPS | -$0.17 | -$0.18 | -$0.29 | -- | -$0.31 | -$0.21 | -$0.35 | -- |
| Diluted EPS | -$0.17 | -$0.18 | -$0.29 | -- | -$0.31 | -$0.21 | -$0.35 | -- |
| Basic Shares Outstanding | 46.1M | 44.8M | 34.1M | -- | 30.3M | 30.2M | 30.1M | -- |
| Diluted Shares Outstanding | 46.1M | 44.8M | 34.1M | -- | 30.3M | 30.2M | 30.1M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $19.94M | $21.35M | $15.65M | $27.22M | $12.10M |
| Short-Term Investments | $38.06M | $62.27M | $91.65M | $68.84M | $46.46M |
| Cash & Short-Term Investments | $58.00M | $83.62M | $107.3M | $99.30M | $58.55M |
| Total Current Assets | $59.94M | $86.26M | $110.5M | $98.62M | $60.11M |
| Long-Term Investments | $2.01M | $5.02M | $27.19M | $3.22M | $3.49M |
| Other Non-Current Assets | $0 | $804K | $1.04M | $720K | -- |
| Total Non-Current Assets | $2.01M | $5.83M | $28.24M | $3.94M | $5.21M |
| Total Assets | $61.95M | $92.09M | $138.7M | $102.6M | $65.32M |
| Accounts Payable | $3.02M | $3.32M | $2.68M | $2.12M | $1.06M |
| Other Current Liabilities | $1.23M | $791K | $666K | -- | -- |
| Total Current Liabilities | $8.72M | $10.24M | $14.04M | $7.19M | $3.40M |
| Other Non-Current Liabilities | $170K | $0 | -- | -- | -- |
| Total Non-Current Liabilities | $170K | $0 | $0 | $2.0K | $13K |
| Total Liabilities | $8.89M | $10.24M | $14.04M | $7.19M | $3.41M |
| Total Debt (incl. Leases) | -- | -- | -- | $53K | -- |
| Retained Earnings | -$240.9M | -$205.8M | -$154.5M | -$89.72M | -$47.38M |
| Accumulated Other Comp. Income | $57K | $31K | $275K | -$374K | -$27K |
| Total Stockholders' Equity | $53.06M | $81.85M | $124.7M | $95.37M | -$47.41M |
| Total Equity | $53.06M | $81.85M | $124.7M | $95.37M | -$47.41M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $20.21M | $44.32M | $53.49M | $19.94M | $18.00M | $18.22M | $19.98M | $21.35M |
| Short-Term Investments | $44.19M | $34.07M | $31.80M | $38.06M | $43.92M | $44.70M | $47.08M | $62.27M |
| Cash & Short-Term Investments | $64.40M | $78.39M | $85.29M | $58.00M | $61.92M | $62.92M | $67.06M | $83.62M |
| Total Current Assets | $65.76M | $79.99M | $87.49M | $59.94M | $64.02M | $67.52M | $69.56M | $86.26M |
| Long-Term Investments | $15.80M | $1.47M | $0 | $2.01M | $3.22M | $8.30M | $11.48M | $5.02M |
| Other Non-Current Assets | $387K | $216K | -- | $0 | $0 | $0 | $304K | $804K |
| Total Non-Current Assets | $16.19M | $1.69M | $0 | $2.01M | $3.22M | $8.30M | $11.78M | $5.83M |
| Total Assets | $81.95M | $81.68M | $87.49M | $61.95M | $67.23M | $75.83M | $81.34M | $92.09M |
| Accounts Payable | $1.66M | $1.97M | $2.62M | $3.02M | $2.23M | $2.11M | $3.07M | $3.32M |
| Other Current Liabilities | $945K | $776K | $567K | $1.23M | $183K | $717K | $369K | $791K |
| Total Current Liabilities | $6.28M | $5.58M | $5.56M | $8.72M | -- | -- | -- | $10.24M |
| Other Non-Current Liabilities | $170K | $170K | $170K | $170K | -- | -- | -- | $0 |
| Total Non-Current Liabilities | $170K | $170K | $170K | $170K | -- | -- | -- | $0 |
| Total Liabilities | $6.45M | $5.75M | $5.73M | $8.89M | $6.86M | $6.98M | $8.01M | $10.24M |
| Retained Earnings | -$267.1M | -$259.2M | -$251.0M | -$240.9M | -$232.2M | -$222.9M | -$216.4M | -$205.8M |
| Accumulated Other Comp. Income | -$207K | -$23K | -$5.0K | $57K | $64K | $25K | $48K | $31K |
| Total Stockholders' Equity | $75.51M | $75.92M | $81.76M | $53.06M | $60.38M | $68.84M | $73.33M | $81.85M |
| Total Equity | $75.51M | $75.92M | $81.76M | $53.06M | $60.38M | $68.84M | $73.33M | $81.85M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Net Income | -$35.17M | -$51.32M | -$64.73M | -$40.96M | -$21.54M |
| Stock-Based Compensation | $6.25M | $8.34M | $8.41M | $4.39M | $974K |
| Change in Payables | -$296K | $641K | $553K | $2.50M | $417K |
| Operating Cash Flow | -$29.83M | -$49.26M | -$53.29M | -$33.46M | -$20.48M |
| Purchases of Investments | -$46.19M | -$46.75M | -$132.2M | -$93.84M | -$77.27M |
| Sales & Maturities of Investments | $74.50M | $101.3M | $88.90M | $72.06M | $27.25M |
| Investing Cash Flow | $28.31M | $54.59M | -$43.28M | -$21.77M | -$50.02M |
| Common Stock Issued | $86K | $147K | $366K | -- | -- |
| Financing Cash Flow | $113K | $372K | $84.99M | $70.36M | $78.53M |
| Net Change in Cash | -$1.41M | $5.70M | -$11.57M | $15.12M | $8.03M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$7.96M | -$8.19M | -$10.03M | -$8.71M | -$9.35M | -$6.46M | -$10.65M | -$7.52M |
| Stock-Based Compensation | $973K | $972K | $1.46M | $1.40M | $801K | $2.00M | $2.05M | $1.78M |
| Change in Payables | $45K | -$998K | -$405K | $795K | $113K | -$960K | -$244K | $1.61M |
| Operating Cash Flow | -$6.10M | -$7.00M | -$12.07M | -$5.24M | -$6.38M | -$7.60M | -$10.62M | -$5.27M |
| Purchases of Investments | -$33.44M | -$13.66M | -$2.70M | -$8.33M | -$3.89M | -$11.67M | -$22.31M | -- |
| Sales & Maturities of Investments | $9.00M | $10.00M | $10.99M | $15.50M | $10.00M | $17.50M | $31.50M | $17.50M |
| Investing Cash Flow | -$24.44M | -$3.66M | $8.29M | $7.17M | $6.11M | $5.83M | $9.19M | -$6.88M |
| Common Stock Issued | -- | -- | -- | $0 | $48K | $0 | $38K | $0 |
| Financing Cash Flow | $6.43M | $1.49M | $37.33M | $0 | $48K | $0 | $65K | $0 |
| Net Change in Cash | -$24.11M | -$9.17M | $33.55M | $1.94M | -$217K | -$1.76M | -$1.37M | -$12.15M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Return on Equity (ROE) | -66.3% | -62.7% | -51.9% | -42.9% | -- |
| Return on Assets (ROA) | -56.8% | -55.7% | -46.7% | -39.9% | -33.0% |
| Current Ratio | 6.87x | 8.43x | 7.87x | 13.72x | 17.70x |
| Quick Ratio | 6.65x | 8.17x | 7.64x | 13.82x | 17.25x |
| Debt to Equity | -- | -- | -- | 0.00x | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -46.1% | -47.7% | -42.2% | -66.2% | -56.3% | -54.3% | -61.8% | -62.7% |
| Return on Assets (ROA) | -42.5% | -44.4% | -39.5% | -56.7% | -50.5% | -49.3% | -55.8% | -55.7% |
| Current Ratio | 10.48x | 14.32x | 15.73x | 6.87x | -- | -- | -- | 8.43x |
| Quick Ratio | 10.26x | 14.04x | 15.33x | 6.65x | -- | -- | -- | 8.17x |